Information  X 
Enter a valid email address

Lowland Inv. Co. (LWI)

  Print          Annual reports

Friday 30 April, 2021

Lowland Inv. Co.

Directorate Change

RNS Number : 2810X
Lowland Investment Co PLC
30 April 2021







30 April 2021





Appointment of New Non-Executive Director


Lowland Investment Company plc is pleased to announce that following a thorough search and selection process, Ms Helena Vinnicombe will be appointed as a non-executive director to the Board with effect from 1 May 2021.  She will also serve as a member of the Company's Audit, Nomination and Management Engagement Committees.


Helena was formerly a senior Partner at Smith & Williamson Investment Management, where she latterly chaired the Asset Allocation Committee as well as being a member of the Investment Strategy Group and Investment Process Committee.  


Robert Robertson, Chairman of Lowland Investment Company plc, said "the Directors and I are delighted to welcome Helena to the Board, bringing, as she does, deep experience of all aspects of investment management, client relationships and sales, strategy and risk management, together with strategic and operational experience in asset allocation, investment research and client management".


Ms Vinnicombe is currently a Trustee for Child Health Research CIO and a member of the Advisory Committee for the M&G Charity Multi-Asset Fund.


In accordance with paragraphs 9.6.13 (1) to (6) of the UKLA Listing Rules, it is confirmed that there are no additional details to be disclosed in relation to Ms Vinnicombe.



For further information, please contact:


Robert Robertson


Lowland Investment Company plc

Telephone: 020 7820 2025


James Henderson

Fund Manager

Lowland Investment Company plc

Telephone: 020 7818 4370


Laura Thomas

Investor Relations and PR Manager

Janus Henderson Investors

Telephone: 020 7818 3198



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t